Ephedrine: A Comprehensive Guide

Ephedrine is a naturally occurring alkaloid derived from plants in the Ephedra genus, with a rich history of medicinal use dating back thousands of years. Traditionally used in Chinese medicine for treating respiratory ailments, ephedrine has become a staple in modern medicine due to its potent stimulant properties. It works primarily by stimulating the sympathetic nervous system, making it a powerful bronchodilator and vasopressor. This dual action not only clears airways but also raises blood pressure, making ephedrine valuable in treating conditions such as nasal congestion, hypotension, and bronchial asthma.

Image source Google

Uses

Ephedrine is used across a range of medical conditions. One of its primary applications is in the treatment of nasal congestion, where its ability to constrict blood vessels reduces swelling and opens airways. Additionally, it is used to treat bronchial asthma by relaxing bronchial muscles, easing breathing. In surgical settings, ephedrine effectively counteracts hypotension during anaesthesia, ensuring stable blood pressure. Moreover, its stimulant effects have led to its use in managing narcolepsy and combating fatigue. While its role in enhancing athletic performance and promoting weight loss is controversial and restricted in many regions, ephedrine remains a subject of interest in sports medicine.

Dosage and Administration

The appropriate dose of ephedrine depends on the condition being treated and the patient’s individual response. For nasal congestion, the typical oral dose for adults is 25 to 50 mg every 4 to 6 hours, with a maximum daily dose of 150 mg. In cases of bronchospasm or hypotension, intravenous or intramuscular injections of 5 to 25 mg may be administered, repeated as necessary. Paediatric dosing is generally lower and tailored according to weight. Healthcare providers closely monitor patients receiving intravenous ephedrine to prevent adverse effects.

Image source Google

Dose Adjustment in Different Diseases

Renal Impairment: Ephedrine is primarily excreted by the kidneys, meaning impaired renal function necessitates dose adjustments. In severe renal impairment, extending the dosing interval is essential to avoid drug accumulation and toxicity.
Hepatic Impairment: Although hepatic metabolism is less significant for ephedrine elimination, caution is warranted. Patients with liver disease may experience prolonged drug effects, necessitating dose reductions and close monitoring.
Pregnancy: Ephedrine crosses the placenta and may impact foetal heart rate and blood pressure. It should only be used during pregnancy when absolutely necessary, under the guidance of a healthcare professional.

Effects and Side Effects

Effects: Ephedrine produces several therapeutic effects, including increased heart rate, enhanced alertness, elevated blood pressure, and bronchodilation, making it a crucial drug in emergencies.
Side Effects: Common side effects include insomnia, anxiety, palpitations, nausea, and dizziness. In rare cases, patients may experience arrhythmias, psychosis, or seizures, particularly at high doses.

Drug Combinations in Use

Ephedrine is frequently combined with other drugs to enhance its effects. For instance, combining ephedrine with caffeine and aspirin is popular in weight-loss supplements and athletic performance enhancers. In clinical settings, ephedrine may be used alongside anaesthetics to mitigate anaesthesia-induced hypotension.

Presentation or Form

Form	Description
Tablets	Convenient for oral administration, commonly used for nasal congestion or mild hypotension.
Capsules	Similar to tablets, often used in weight-loss or energy-boosting supplements.
Injections	Administered intravenously or intramuscularly, used in emergency settings to treat hypotension and bronchospasm.
Nasal Sprays	Provides rapid relief for nasal congestion by directly constricting blood vessels in the nasal mucosa.
Herbal Preparations	Traditional remedies containing ephedrine alkaloids, primarily used in Chinese medicine for respiratory conditions.

Pharmacokinetics and Pharmacodynamics

Pharmacokinetics: Ephedrine is rapidly absorbed after oral administration, reaching peak plasma concentrations within 1 to 2 hours. It has a half-life of about 3 to 6 hours and is primarily excreted unchanged in the urine.
Pharmacodynamics: As a sympathomimetic agent, ephedrine acts on both alpha and beta-adrenergic receptors. It enhances the release of noradrenaline while directly stimulating receptors, resulting in increased cardiac output, bronchodilation, and vasoconstriction.

Drug Interaction

Ephedrine interacts with various medications, sometimes with serious consequences. Concurrent use with monoamine oxidase inhibitors (MAOIs) can lead to hypertensive crises. Combining ephedrine with beta-blockers may blunt its effects, while other sympathomimetic agents can exacerbate cardiovascular side effects.

Comparison with Other Drugs in the Same Category

Drug	Mechanism of Action	Primary Use	Side Effects
Ephedrine	Indirect and direct sympathomimetic	Hypotension, nasal congestion	Insomnia, palpitations
Pseudoephedrine	Indirect sympathomimetic	Nasal congestion	Mild insomnia, dry mouth
Phenylephrine	Direct alpha-adrenergic agonist	Hypotension, nasal congestion	Reflex bradycardia
Norepinephrine	Direct sympathomimetic	Acute hypotension, shock	Arrhythmias, tissue necrosis
Dopamine	Dopaminergic and adrenergic agonist	Shock, heart failure	Tachycardia, arrhythmias

Precautions and Special Considerations

Patients with pre-existing cardiovascular disease, hyperthyroidism, diabetes, or glaucoma should use ephedrine with extreme caution. Extended use can lead to tolerance, requiring higher doses for the same effect. Discontinuation after prolonged use may result in withdrawal symptoms.

Toxicity or Overdose and Antidote

In cases of overdose, symptoms such as severe hypertension, tachycardia, seizures, and arrhythmias may occur. Treatment involves supportive care, with benzodiazepines administered for seizures and beta-blockers used to control cardiac symptoms.

Recent Updates in 2025 and Guidelines

As of 2025, new guidelines emphasise stricter monitoring protocols for patients receiving ephedrine, reflecting concerns over misuse and cardiovascular risk. Healthcare providers are advised to initiate treatment at lower doses and closely monitor patient responses, especially in those with comorbidities.

Facts to Remember

Ephedrine stimulates both alpha and beta-adrenergic receptors, making it versatile in treating various conditions.
Rapid onset of action, particularly with intravenous administration.
Prolonged use leads to tolerance and may necessitate dose escalation.
Combining ephedrine with other stimulants significantly raises the risk of adverse cardiovascular effects.

References

British National Formulary (BNF), 2025 Edition.
European Medicines Agency Guidelines on Sympathomimetics, 2025.
Journal of Clinical Pharmacology, January 2025.
National Institute for Health and Care Excellence (NICE) Guidelines, 2025.
Ephedrine Pharmacology and Therapeutics by Dr. J. Collins, 2024.
World Health Organization Report on Sympathomimetic Agents, 2025.
Clinical Pharmacology and Therapeutics Review, March 2025.

Ephedrine remains a vital medication with diverse applications, but its use requires careful consideration to balance its therapeutic benefits with potential risks. As research continues to evolve, updated guidelines will ensure safer prescribing practices, enabling healthcare providers to use this powerful drug effectively.

You should also Know about